Theresa Heggie, Senior VP of Global Commercial Operations at Shire Human Genetic Therapies, presented at last year's World Orphan Drug Congress USA on the topic â€˜The development and commercialization of drugs for patients with orphan diseases.'
Do you want to learn more about:
- Encouraging responsibility and urgency to meet patients' needs
- Partnering long-term with patient organizations, healthcare professionals and payers
- Engaging employees through Shire's BRAVE culture
If so, you need to check out the video below: